Urology department - faculty of medicine, South Valley university
Qina, Egypt
NCT Number: NCT05413603
Epidemiological studies have shown a progressive increase in the incidence of pediatric urolithiasis over the past few decades.
Looking for future studies?
Notify Me2 year–16 year
All sexes
Interventional
Not applicable
Qina, Egypt
Pediatric stone disease is considered endemic in developing nations including Turkey, Pakistan, and eastern countries. The introduction of SWL by Chaussy et al. in the early 1980s revolutionized the management of upper urinary tract calculus disease.
Reports of successful SWL in children were first published in 1986; then several reports showed safety, and stone-free rates comparable with those of adults. For successful SWL, accurate localization of the shock waves is performed by ultrasound (US) or fluoroscope (FS) to fully focus the shock waves on the stone
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
successful Shock wave lithotripsy , accurate localization of the shock waves is performed by ultrasound (US) to fully focus the shock waves on the stone
successful Shock wave lithotripsy , accurate localization of the shock waves is performed by fluoroscope (FS) to fully focus the shock waves on the stone
Time frame: from baseline to 3 months after the Lithotripsy date.
Incidence of success of Nephrolithotripsy by using Fluoroscopic shock waves or Ultrasonic shock waves in pediatric renal pelvic stones.
Time frame: through study completion, an average of 1 year
to evaluate postoperative complications of the lithotripsy as :
Egymedicalpedia
Industry
Shock Wave Lithotripsy Using Fluoroscopic Versus Ultrasonic Localization for Pediatric Renal Stones.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07445646
Calculi, Female Urogenital Diseases
Zagazig, Egypt
View Trial DetailsNCT07052188
Calculi, Female Urogenital Diseases
Adıyaman, Turkey (Türkiye)
View Trial DetailsNCT05646069
Calculi, Female Urogenital Diseases
Chicago, Illinois, United States
View Trial DetailsNCT06381206
Calculi, Female Urogenital Diseases
Damascus, Syria
View Trial Details